Skip to main content
. 2017 Apr 18;38(3):163–186. doi: 10.1002/bdd.2068

Table 3.

Pharmacokinetic data in humans and rats

Humans Rats
i.v. dose mg oral dose mg F CL l/h Vss l/kg f up R b Urinary excretion (f e) % of dose i.v. dose mg oral dose mg F CL ml/min/kg f up R b
1 Alprazolam 1 1 0.96 3.11 0.72 0.29 0.78 20 0.48 2.67 0.28 133 0.35 0.81
2 Alprenolol 7.25 100 0.06 65.90 2.99 0.18 0.76 0.5 0.5 2.5 0.04 79 1.71
3 Chlorpromazine 10 50 0.31 76.6 8.88 0.06 1.2 < 1 2.5 2.5 0.02 52 0.01 1.48
4 Clozapine 25 200 0.86 13.02 1.6 0.06 0.86 < 1 0.96 3.84 0.05 77.5 0.1 **
5 Cyclosporine 111.45 371.5 0.39 16.50 1.1 0.07 1.36 < 1 1.18 1.18 0.2 2 0.06 1.28
6 Diltiazem 20 120 0.47 48.3 5.2 0.18 1.00 3 1.43 4.28 0.06 42 0.18 0.93
7 Domperidone 10 10 0.39 42.06 5.71 0.08 0.74 < 1 0.63 0.63 0.5 39.2 0.09 1.3
8 Erythromycin 500 500 0.21 18.73 0.60 0.1 0.91 12 0.58 5.63 0.14 105 0.48 **
9 Felodipine 2.5 27.5 0.25 49.4 4.4 0.004 0.7 < 1 0.03 0.74 0.1 61 0.001 0.68
10 Flumazenil 2 30 0.22 72.06 0.97 0.58 1 0.5 0.56 5.63 0.28 147 0.14 **
11 Itraconazole 100 100 0.76 22.86 7.4 0.002 * < 1 3 3 0.35 9.1 0.009 **
12 Lidocaine 200 300 0.42 42 1.34 0.33 0.87 8 4.25 21.25 0.02 31.8 0.38 1.27
13 Metoprolol 5 5 0.36 65.34 5.18 0.88 1.1 10 0.23 0.23 0.23 65.2 0.80 1.5
14 Midazolam 10.5 20 0.7 19.38 0.74 0.02 0.75 < 1 2.75 4.13 0.25 46 0.06 0.81
15 Mirtazapine 3.5 15 0.4 38.3 3.52 0.15 0.67 4 0.55 2.75 0.07 29.4 0.11 **
16 Nalbuphine 20 60 0.12 90 4.63 0.5 * 7 0.66 6 0.01 63 0.25 **
17 Nicardipine 15 30 0.45 34.57 0.76 0.01 0.71 0 1.14 3.42 0.22 115 0.01 **
18 Nifedipine 1.46 20 0.47 36 1.67 0.04 0.67 0 0.25 0.75 0.46 8.7 0.004 **
19 Nimodipine 2.1 60 0.33 58.8 0.94 0.02 * < 0.1 0.86 3.42 0.22 1.5 0.03 **
20 Nisoldipine 0.37 20 0.04 50.82 4.1 0.003 * < 1 0.2 0.2 0.03 45.8 0.009 **
21 Nitrendipine 2 20 0.39 78.89 5.39 0.01 1.46 < 1 1 1 0.12 16.5 0.04 1.46
22 Omeprazole 10 10 0.32 39.48 0.24 0.05 0.59 0 1.33 5.3 0.09 39.2 0.13 0.66
23 Saquinavir 12 600 0.01 60.6 3.63 0.03 0.74 1 2.35 11.75 0.07 88.5 0.05 0.82
24 Sildenafil 50 50 0.41 40.08 1.4 0.04 0.64 0 2.85 2.85 0.06 38.5 0.05 0.56
25 Tacrolimus 1.55 3.88 0.21 78.75 1.74 0.01 35 < 1 0.43 2.13 0.11 16.5 ** 1.4
26 Tolterodine 1.28 3.2 0.72 27.72 1.4 0.04 * 1 0.13 3 0.02 166.7 0.15 **
27 Triazolam 0.25 0.25 0.8 12.72 0.58 0.1 0.62 2 0.64 1.28 0.16 51.4 0.28 1.5
28 Venlafaxine 10 50 0.37 60.35 4.4 0.73 1.0 4.6 7.26 7.26 0.13 64.5 0.59 **
29 Verapamil 10 120 0.39 49.7 4 0.09 0.89 < 3 0.13 1.25 0.06 29.3 0.05 0.85
30 Zolmitriptan 3.5 10 0.7 43.06 1.8 0.75 * 8 0.13 0.13 0.41 29.4 **
31 Zolpidem 5 5 0.78 18.85 0.68 0.08 0.66 < 1 0.25 0.25 0.27 15 0.13 0.86
*

When no data were available, a value of R b of 0.55 should be considered if the drug is an acid, or a value of R b of 1 if the drug is basic or neutral 56.

**

When rat values were not available, human values were considered.

References for f up, R b and urinary excretion are found in Supplemental Table S1.

References for i.v. and oral dose, F, CL, Vss are found in Supplemental Table S2.

Note: Rat Vss values were not needed and human urinary excretion values were used for rat.